Danaher Corporation $DHR Shares Sold by Allianz SE

Allianz SE reduced its position in shares of Danaher Corporation (NYSE:DHR) by 11.0% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 31,125 shares of the conglomerate’s stock after selling 3,830 shares during the quarter. Allianz SE’s holdings in Danaher were worth $6,171,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in DHR. WFA of San Diego LLC acquired a new stake in shares of Danaher during the second quarter worth $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the 2nd quarter valued at about $27,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher during the 3rd quarter valued at about $27,000. TruNorth Capital Management LLC bought a new position in Danaher in the third quarter worth about $28,000. Finally, Tripletail Wealth Management LLC bought a new position in Danaher in the third quarter worth about $31,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on DHR. Leerink Partners increased their price target on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research report on Friday, January 16th. HSBC upped their price objective on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Monday, December 1st. Morgan Stanley initiated coverage on Danaher in a research note on Monday, December 1st. They issued an “overweight” rating and a $270.00 target price on the stock. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $253.86.

Danaher Stock Up 0.4%

DHR opened at $210.28 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The company has a market capitalization of $148.70 billion, a PE ratio of 41.72, a P/E/G ratio of 2.83 and a beta of 0.91. The stock’s fifty day moving average is $225.33 and its 200-day moving average is $216.16. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. During the same quarter last year, the firm posted $2.14 EPS. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. This is a positive change from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date is Friday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.